Biomarkers in Barrett's oesophagus

dc.contributor.authorMarais M.
dc.date.accessioned2011-05-15T16:18:00Z
dc.date.available2011-05-15T16:18:00Z
dc.date.issued2009
dc.description.abstract[No abstract available]
dc.description.versionReview
dc.identifier.citationSouth African Gastroenterology Review
dc.identifier.citation7
dc.identifier.citation1
dc.identifier.issn18121659
dc.identifier.urihttp://hdl.handle.net/10019.1/14466
dc.publisherSouth African Gastroenterology Review
dc.subjectbiological marker
dc.subjectcyclin D1
dc.subjectcyclin dependent kinase inhibitor
dc.subjectcycline
dc.subjectcyclooxygenase 2
dc.subjectDNA
dc.subjectKi 67 antigen
dc.subjectprotein c Myb
dc.subjectprotein p16
dc.subjectprotein p53
dc.subjectretinoblastoma protein
dc.subjecttranscription factor Cdx1
dc.subjecttranscription factor Cdx2
dc.subjecttumor suppressor protein
dc.subjectvasculotropin A
dc.subjectvasculotropin C
dc.subjectBarrett esophagus
dc.subjectcancer incidence
dc.subjectcell cycle G1 phase
dc.subjectcell cycle S phase
dc.subjectcell proliferation
dc.subjectchromosome 17p
dc.subjectchromosome 9p
dc.subjectdiagnostic value
dc.subjectdisease association
dc.subjectDNA content
dc.subjectendoscopic biopsy
dc.subjectesophageal adenocarcinoma
dc.subjectesophagoscopy
dc.subjectflow cytometry
dc.subjectgastroesophageal reflux
dc.subjectgene mutation
dc.subjectheterozygosity loss
dc.subjecthistopathology
dc.subjecthuman
dc.subjectimmunohistochemistry
dc.subjectmalignant transformation
dc.subjectobesity
dc.subjectphase transition
dc.subjectploidy
dc.subjectreview
dc.subjectrisk assessment
dc.titleBiomarkers in Barrett's oesophagus
dc.typeReview
Files